Genenta Science SpA ADR (GNTA) Peer Comparison

$1.02

$0.03 (2.96%)

As on 28-Aug-2026 13:35EDT

Market cap

$61 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Edit

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Market cap ($ Mln)	61	16,614
Revenue (€ Mln)	--	1,054
Net Profit (€ Mln)	-6.27	755.85
Net Margin (%)	--	71.69
RoE (%)	-36.53	--
Price to Earnings	--	19.38
Price-To-Book	2.27	10.05

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (€ Mln)

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Operating Revenue	0.00	691.71
Cost of Revenue	0.03	103.18
Gross Profit	-0.03	588.53
Operating Expenses	6.32	719.42
Operating Profit (EBIT)	-6.34	-130.89
Other Income	--	--
Profit before Tax	-6.27	-204.26
Provision for Tax	--	14.78
Profit after Tax (Net Income)	-6.27	-219.03
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities (€ Mln)

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Shareholder's Funds	21.84	-162.75
Minority Interest	--	--
Non-Current Liabilities	7.93	395.83
Current Liabilities	2.12	1,068.94
Total Liabilities	31.89	1,302.02

Assets (€ Mln)

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Non-Current Assets	1.91	193.50
Current Assets	29.98	1,108.51
Total Assets	31.89	1,302.02
Total Debt*	7.60	871.41
Net Current Assets	27.86	39.59

Cashflow (€ Mln)

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Cash From Operating Activities	-6.87	51.77
Cash Flow from Investing Activities	-14.54	-8.15
Cash from Financing Activities	22.29	34.89
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
ROCE (%)	-29.90	-30.01
ROE (%)	-36.53	163.18
ROA (%)	-26.85	-17.65
EBIT Margin (%)	--	--
Net Margin (%)	--	-31.67
Cash Profit Margin (%)	--	--

Growth Ratios

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Revenue Growth (%)	--	0.90
EBIT Growth (%)	--	--
Net Profit Growth (%)	32.63	42.07
EPS Growth (%)	0.34	0.44
Book Value Growth (%)	--	--

Valuation Ratios

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Price / Earnings	-4.46	-59.76
Price / Book Value	1.28	-80.42
Dividend Yield (%)	--	--
EV/EBITDA	-1.27	-121.54
Market Cap ($ Cr)	--	--

Solvency Ratios

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Debt to Equity	0.35	-5.35
Short term debt to equity ratio	--	-2.99
Current Ratio	14.16	1.04
Quick Ratio	--	0.76
Interest Coverage	-15.32	-1.64

Operating Efficiency Ratios

	Genenta Science SpA ADR (GNTA)	Ascendis Pharma A/S - ADR
Debtors to sales (%)	--	22.79
Asset Turnover	0.00	0.56
Receivable days	--	85.52
Inventory Days	--	1,056.70
Payable days	12,370.65	331.01
Cash Conversion Cycle	--	811.21

Annual
Quarterly